Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Lucy Shapiro, Lars Holmkvist

Premium

Pacific Biosciences has appointed Lucy Shapiro to its board of directors. Shapiro is currently the Virginia and D.K. Ludwig professor of cancer research and director of the Beckman Center for Molecular and Genetic Medicine at Stanford University's School of Medicine. She has been a faculty member at Stanford since 1989. Shapiro is also a co-founder and director of Anacor Pharmaceuticals. She holds a BA from Brooklyn College and a PhD in molecular biology from the Albert Einstein College of Medicine.



Agilent Technologies
has named Lars Holmkvist as a senior vice president and president of its Diagnostics and Genomics group. Holmkvist was president and CEO of diagnostic developer Dako, which Agilent acquired in June. He joined Dako from Applied Biosystems and previously was at Medtronic Vascular and Cardiac Surgery.
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.